Last reviewed · How we verify
Bolus vitamin D3
At a glance
| Generic name | Bolus vitamin D3 |
|---|---|
| Also known as | Bolus cholecalciferol |
| Sponsor | Medical University of South Carolina |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion (PHASE3)
- Daily Vitamin D for Sickle-cell Respiratory Complications (PHASE2)
- A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients (PHASE4)
- Monthly Boluses Versus Daily Doses for Correcting Blood Vitamin D Deficit in Obese Children and Adolescents (PHASE3)
- Effect of Vitamin D Supplementation on Glutathione Peroxidase (GPx) Activity, Interleukin-6 (IL-6) Levels and Clinical Outcomes in Post-COVID-19 Patients (NA)
- Effectiveness and Safety of Two Vitamin D3 Supplementation Regimens in Adults with Early-stage COVID-19 (NA)
- Epigenetic Memory of Vitamin D Supplementation (PHASE1)
- Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bolus vitamin D3 CI brief — competitive landscape report
- Bolus vitamin D3 updates RSS · CI watch RSS
- Medical University of South Carolina portfolio CI